STOCK TITAN

Nexentis Technologies (NXTS) 424B Filings

NXTS NASDAQ

Ticker history: NITO became NXTS (Nexentis Technologies Inc.) on . Earlier news and filings retain their original names and dates. View NITO history.

Here are the 424B prospectus supplements from Nexentis Technologies Inc. (NXTS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 424B covers the supplement that carries the terms of a priced offering, so if you follow NXTS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NXTS filings page.

Rhea-AI Summary

Nexentis Technologies Inc. is registering 410,998 shares of common stock. The company is offering 410,998 shares at $7.056 per share in a registered direct placement, with aggregate gross proceeds to the company of $2,900,001.88. In a concurrent private placement to the same investors, Nexentis is issuing unregistered warrants to purchase up to 410,998 shares at an exercise price of $7.056 per share, exercisable immediately and expiring five years after issuance. The prospectus states net proceeds will be used for general corporate purposes and working capital. Shares outstanding used to calculate post-offering figures were 1,042,335 as of June 22, 2026, and delivery was expected on or about June 23, 2026.

Rhea-AI Summary

Nexentis Technologies Inc. is offering 311,876 shares of common stock at $4.008 per share pursuant to this prospectus supplement, with delivery expected on or about June 15, 2026. In a concurrent private placement to the same investors, Nexentis is issuing unregistered warrants to purchase up to 311,876 shares at an exercise price of $4.008 per share, exercisable immediately and expiring five years from issuance.

The prospectus supplement states estimated gross proceeds to Nexentis of $1,249,999.08 (before expenses) and intends to use net proceeds for general corporate purposes and working capital. The filing also discloses a beneficial ownership limitation on warrant exercises of 4.99% (or, at holder election before issuance, 9.99%) of outstanding common stock and that warrants will not be listed on any national exchange.